Head/Neck Cancer

Top Story

World Trade Center responders at increased risk for head and neck cancers

January 17, 2019
In the Journals Plus

Treatment de-intensification fails to reduce toxicity, maintain efficacy in HPV-positive oropharyngeal cancer

January 17, 2019
Patients with advanced, HPV-positive
Feature

‘Cancer-agnostic’ NTRK inhibitor approval ushers in paradigm of personalized genomics-guided therapeutics

HemOnc Today, January 10, 2019
Patrick C. Ma, MD, MSc
On Nov. 26, the FDA announced the accelerated approval of larotrectinib as the first small molecule inhibitor for use in a “cancer-agnostic” manner, in…
In the Journals PlusPerspective

US cancer deaths down 27% in 25 years, but socioeconomic gaps widening

January 8, 2019
The overall rate of cancer deaths in the U.S. has declined by 27% during the past 25 years, with approximately 2.6 million fewer cancer deaths reported between 1991 and…
More Headlines »
CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »
Video
Meeting News

VIDEO: Anti-CD47 fusion protein well tolerated by patients with solid tumors, non-Hodgkin lymphoma

June 24, 2018
More »